Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast calculations
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Transcatheter heart valve replacement industry 3600 synopsis, 2015 - 2026
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Surgical approach trends
2.1.4 Application trends
2.1.5 End-use trends
2.1.6 Regional Trends
Chapter 3 Transcatheter Heart Valve Replacement Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2015 – 2026
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Rise in venture capital investments for transcatheter heart valve devices by major players in North America and Europe
3.3.1.2 Increasing technological advancements in surgical procedures for transcatheter heart valve replacement in Europe
3.3.1.3 Favourable reimbursement scenario in North America and Europe
3.3.1.4 Increasing prevalence of valvular heart disease in developing regions of Asia Pacific
3.3.1.5 Rising interest of manufacturers in emerging markets such as Middle East and Africa
3.3.2 Industry pitfalls & challenges
3.3.2.1 High cost and risk associated with the transcatheter heart valve replacement procedures in Asia Pacific
3.3.2.2 Stringent government regulations in developing regions
3.3.2.3 Insufficient healthcare infrastructures in Latin America
3.3.2.4 Lack of awareness regarding new minimally invasive surgical procedures and inadequate medical facilities in MEA
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By surgical approach
3.4.3 By application
3.4.4 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Porter’s analysis
3.8 Competitive landscape, 2019
3.8.1 Competitive matrix analysis, 2019
3.9 PESTEL analysis
Chapter 4 Transcatheter Heart Valve Replacement Market, By Product
4.1 Key segment trends
4.2 Transcatheter Aortic Valve Replacement
4.2.1 Market size, by region, 2015 – 2026 (USD Million)
4.2.2 Market size, by region, 2015 – 2026 (Units)
4.3 Transcatheter Mitral Valve Repair and Replacement
4.3.1 Market size, by region, 2015 – 2026 (USD Million)
4.3.2 Market size, by region, 2015 – 2026 (Units)
4.4 Transcatheter Pulmonary Valve Replacement
4.4.1 Market size, by region, 2015 – 2026 (USD Million)
4.4.2 Market size, by region, 2015 – 2026 (Units)
Chapter 5 Transcatheter Heart Valve Replacement Market, By Surgical Approach
5.1 Key segment trends
5.2 Transfemoral Approach
5.2.1 Market size, by region, 2015 – 2026 (USD Million)
5.3 Transapical Approach
5.3.1 Market size, by region, 2015 – 2026 (USD Million)
5.4 Others
5.4.1 Market size, by region, 2015 – 2026 (USD Million)
Chapter 6 Transcatheter Heart Valve Replacement Market, By Application
6.1 Key segment trends
6.2 Aortic Valvular Heart Disease
6.2.1 Market size, by region, 2015 – 2026 (USD Million)
6.2.2 Aortic Valve Stenosis
6.2.2.1 Market size, by region, 2015- 2016 (USD Million)
6.2.3 Aortic Valve Regurgitation
6.2.3.1 Market size, by region, 2015- 2016 (USD Million)
6.3 Mitral Valvular Heart Disease
6.3.1 Market size, by region, 2015 – 2026 (USD Million)
6.3.2 Mitral Valve Stenosis
6.3.2.1 Market size, by region, 2015- 2016 (USD Million)
6.3.3 Mitral Valve Regurgitation
6.3.3.1 Market size, by region, 2015- 2016 (USD Million)
6.4 Pulmonary Valvular Heart Disease
6.4.1 Market size, by region, 2015-2016 (USD Million)
Chapter 7 Transcatheter Heart Valve Replacement Market, By End-use
7.1 Key segment trends
7.2 Hospitals
7.2.1 Market size, by region, 2015 – 2026 (USD Million)
7.3 Cath Labs
7.3.1 Market size, by region, 2015 – 2026 (USD Million)
Chapter 8 Transcatheter Heart Valve Replacement Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2015 -2026 (USD Million)
8.2.2 Market size, by country, 2015 -2026 (Units)
8.2.3 Market size, by product, 2015– 2026 (USD Million)
8.2.4 Market size, by product, 2015 – 2026 (Units)
8.2.5 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.2.6 Market size, by application, 2015-2026 (USD Million)
8.2.6.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.2.6.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.2.7 Market size, by end-use, 2015-2026 (USD Million)
8.2.8 U.S.
8.2.8.1 Market size, by product, 2015– 2026 (USD Million)
8.2.8.2 Market size, by product, 2015 – 2026 (Units)
8.2.8.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.2.8.4 Market size, by application, 2015-2026 (USD Million)
8.2.8.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.2.8.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.2.8.5 Market size, by end-use, 2015-2026 (USD Million)
8.2.9 Canada
8.2.9.1 Market size, by product, 2015– 2026 (USD Million)
8.2.9.2 Market size, by product, 2015 – 2026 (Units)
8.2.9.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.2.9.4 Market size, by application, 2015-2026 (USD Million)
8.2.9.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.2.9.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.2.9.5 Market size, by end-use, 2015-2026 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2015 -2026 (USD Million)
8.3.2 Market size, by country, 2015 -2026 (Units)
8.3.3 Market size, by product, 2015– 2026 (USD Million)
8.3.4 Market size, by product, 2015 – 2026 (Units)
8.3.5 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.3.6 Market size, by application, 2015-2026 (USD Million)
8.3.6.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.3.6.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.3.7 Market size, by end-use, 2015-2026 (USD Million)
8.3.8 Germany
8.3.8.1 Market size, by product, 2015– 2026 (USD Million)
8.3.8.2 Market size, by product, 2015 – 2026 (Units)
8.3.8.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.3.8.4 Market size, by application, 2015-2026 (USD Million)
8.3.8.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.3.8.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.3.8.5 Market size, by end-use, 2015-2026 (USD Million)
8.3.9 UK
8.3.9.1 Market size, by product, 2015– 2026 (USD Million)
8.3.9.2 Market size, by product, 2015 – 2026 (Units)
8.3.9.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.3.9.4 Market size, by application, 2015-2026 (USD Million)
8.3.9.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.3.9.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.3.9.5 Market size, by end-use, 2015-2026 (USD Million)
8.3.10 France
8.3.10.1 Market size, by product, 2015– 2026 (USD Million)
8.3.10.2 Market size, by product, 2015 – 2026 (Units)
8.3.10.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.3.10.4 Market size, by application, 2015-2026 (USD Million)
8.3.10.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.3.10.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.3.10.5 Market size, by end-use, 2015-2026 (USD Million)
8.3.11 Spain
8.3.11.1 Market size, by product, 2015– 2026 (USD Million)
8.3.11.2 Market size, by product, 2015 – 2026 (Units)
8.3.11.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.3.11.4 Market size, by application, 2015-2026 (USD Million)
8.3.11.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.3.11.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.3.11.5 Market size, by end-use, 2015-2026 (USD Million)
8.3.12 Italy
8.3.12.1 Market size, by product, 2015– 2026 (USD Million)
8.3.12.2 Market size, by product, 2015 – 2026 (Units)
8.3.12.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.3.12.4 Market size, by application, 2015-2026 (USD Million)
8.3.12.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.3.12.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.3.12.5 Market size, by end-use, 2015-2026 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2015 -2026 (USD Million)
8.4.2 Market size, by country, 2015 -2026 (Units)
8.4.3 Market size, by product, 2015– 2026 (USD Million)
8.4.4 Market size, by product, 2015 – 2026 (Units)
8.4.5 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.4.6 Market size, by application, 2015-2026 (USD Million)
8.4.6.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.4.6.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.4.7 Market size, by end-use, 2015-2026 (USD Million)
8.4.8 Japan
8.4.8.1 Market size, by product, 2015– 2026 (USD Million)
8.4.8.2 Market size, by product, 2015 – 2026 (Units)
8.4.8.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.4.8.4 Market size, by application, 2015-2026 (USD Million)
8.4.8.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.4.8.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.4.8.5 Market size, by end-use, 2015-2026 (USD Million)
8.4.9 China
8.4.9.1 Market size, by product, 2015– 2026 (USD Million)
8.4.9.2 Market size, by product, 2015 – 2026 (Units)
8.4.9.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.4.9.4 Market size, by application, 2015-2026 (USD Million)
8.4.9.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.4.9.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.4.9.5 Market size, by end-use, 2015-2026 (USD Million)
8.4.10 India
8.4.10.1 Market size, by product, 2015– 2026 (USD Million)
8.4.10.2 Market size, by product, 2015 – 2026 (Units)
8.4.10.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.4.10.4 Market size, by application, 2015-2026 (USD Million)
8.4.10.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.4.10.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.4.10.5 Market size, by end-use, 2015-2026 (USD Million)
8.4.11 Australia
8.4.11.1 Market size, by product, 2015– 2026 (USD Million)
8.4.11.2 Market size, by product, 2015 – 2026 (Units)
8.4.11.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.4.11.4 Market size, by application, 2015-2026 (USD Million)
8.4.11.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.4.11.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.4.11.5 Market size, by end-use, 2015-2026 (USD Million)
8.4.12 South Korea
8.4.12.1 Market size, by product, 2015– 2026 (USD Million)
8.4.12.2 Market size, by product, 2015 – 2026 (Units)
8.4.12.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.4.12.4 Market size, by application, 2015-2026 (USD Million)
8.4.12.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.4.12.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.4.12.5 Market size, by end-use, 2015-2026 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2015 -2026 (USD Million)
8.5.2 Market size, by country, 2015 -2026 (Units)
8.5.3 Market size, by product, 2015– 2026 (USD Million)
8.5.4 Market size, by product, 2015 – 2026 (Units)
8.5.5 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.5.6 Market size, by application, 2015-2026 (USD Million)
8.5.6.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.5.6.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.5.7 Market size, by end-use, 2015-2026 (USD Million)
8.5.8 Brazil
8.5.8.1 Market size, by product, 2015– 2026 (USD Million)
8.5.8.2 Market size, by product, 2015 – 2026 (Units)
8.5.8.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.5.8.4 Market size, by application, 2015-2026 (USD Million)
8.5.8.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.5.8.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.5.8.5 Market size, by end-use, 2015-2026 (USD Million)
8.5.9 Mexico
8.5.9.1 Market size, by product, 2015– 2026 (USD Million)
8.5.9.2 Market size, by product, 2015 – 2026 (Units)
8.5.9.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.5.9.4 Market size, by application, 2015-2026 (USD Million)
8.5.9.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.5.9.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.5.9.5 Market size, by end-use, 2015-2026 (USD Million)
8.5.10 Argentina
8.5.10.1 Market size, by product, 2015– 2026 (USD Million)
8.5.10.2 Market size, by product, 2015 – 2026 (Units)
8.5.10.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.5.10.4 Market size, by application, 2015-2026 (USD Million)
8.5.10.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.5.10.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.5.10.5 Market size, by end-use, 2015-2026 (USD Million)
8.6 Middle East & Africa
8.6.1 Market size, by country, 2015 -2026 (USD Million)
8.6.2 Market size, by country, 2015 -2026 (Units)
8.6.3 Market size, by product, 2015– 2026 (USD Million)
8.6.4 Market size, by product, 2015 – 2026 (Units)
8.6.5 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.6.6 Market size, by application, 2015-2026 (USD Million)
8.6.6.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.6.6.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.6.7 Market size, by end-use, 2015-2026 (USD Million)
8.6.8 South Africa
8.6.8.1 Market size, by product, 2015– 2026 (USD Million)
8.6.8.2 Market size, by product, 2015 – 2026 (Units)
8.6.8.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.6.8.4 Market size, by application, 2015-2026 (USD Million)
8.6.8.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.6.8.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.6.8.5 Market size, by end-use, 2015-2026 (USD Million)
8.6.9 Saudi Arabia
8.6.9.1 Market size, by product, 2015– 2026 (USD Million)
8.6.9.2 Market size, by product, 2015 – 2026 (Units)
8.6.9.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.6.9.4 Market size, by application, 2015-2026 (USD Million)
8.6.9.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.6.9.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.6.9.5 Market size, by end-use, 2015-2026 (USD Million)
8.6.10 UAE
8.6.10.1 Market size, by product, 2015– 2026 (USD Million)
8.6.10.2 Market size, by product, 2015 – 2026 (Units)
8.6.10.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.6.10.4 Market size, by application, 2015-2026 (USD Million)
8.6.10.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.6.10.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.6.10.5 Market size, by end-use, 2015-2026 (USD Million)
8.6.11 Israel
8.6.11.1 Market size, by product, 2015– 2026 (USD Million)
8.6.11.2 Market size, by product, 2015 – 2026 (Units)
8.6.11.3 Market size, by surgical approach, 2015 – 2026 (USD Million)
8.6.11.4 Market size, by application, 2015-2026 (USD Million)
8.6.11.4.1 Market size, by aortic valvular heart disease, 2015-2026 (USD Million)
8.6.11.4.2 Market size, by mitral valvular heart disease, 2015-2026 (USD Million)
8.6.11.5 Market size, by end-use, 2015-2026 (USD Million)
Chapter 9 Company Profiles
9.1 Competitive dashboard, 2019
9.2 4C Medical Technologies
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Abbott
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Boston Scientific
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Edwards Lifesciences
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 HighLife Medical
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 JC Medical
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 LivaNova
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Medtronic plc
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Meril Lifesciences
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Micro Interventional Devices
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 Neovasc
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
